Annoviant secured a $2.99 million NIH grant, along with matching funds from investors, to advance its TxGuard pulmonary-valved conduit for pediatric heart disease. The technology, resistant to calcification and thrombosis, aims to provide durable pulmonary valved grafts that adapt and regenerate alongside patients, minimizing the need for multiple re-operations over their lifetime.
Exo has expanded its FDA-cleared AI applications to its handheld ultrasound device, Exo Iris, enabling caregivers to diagnose cardiac and lung conditions at point of care. Trained on over 100,000 real-world ultrasound scans, Exo’s AI offers reliable assessments for conditions like pulmonary edema and heart failure, promising more accessible and reliable healthcare for all.
The OncoPen, seamlessly integrated with the MOLLI 2 System, revolutionizes breast cancer surgery with its precise 3D guidance and wire-free design, improving patient experience and surgical flexibility. Dr. Jaime Alberty, director of The Comprehensive Breast Center at NYC Health + Hospitals/Kings County, praises the OncoPen’s impact on enhancing surgical precision and delivering compassionate care, highlighting its significance in advancing minimally invasive techniques for breast cancer treatment.
The FDA grants Blue Arbor Technologies’s RESTORE Neuromuscular Interface System breakthrough device designation, marking a significant advancement in prosthetic control for individuals with upper limb loss. This system offers a direct connection to residual muscles and nerves, surpassing skin electrode technologies, and aims to revolutionize prosthetic devices by restoring natural hand and arm functions with reliable and voluntary movement control signals.
CroíValve introduces a unique approach to treating tricuspid regurgitation with its Duo system, aiming to provide a solution beyond existing options from Abbott and Edwards. The Duo system is designed to sit inside the tricuspid valve, allowing native leaflets to seal against it, restoring their function and offering a straightforward procedure with meaningful improvement in patient symptoms while avoiding safety events seen with other options. CEO Lucy O’Keeffe highlights the system’s unique features, including its anchoring system, catheter arm, and compatibility with diverse patient populations, aiming for broad adoption and ease of use among physicians.
ThinkMedTek 
Leave a comment